SecBot SecBot
SECBOTREPLAY Home › Report › TNGX

TNGX · FMR stake 15.0% of TNGX

Tango Therapeutics, Inc. · SC 13G/A filed Nov 6, 2026 at 09:45 ET

At the news

NEUTRALIMPACT 2/10

SC 13G/A filed Nov 6, 2026 at 09:45 ET

FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 25,286,624 shares of Tango Therapeutics common stock as of October 30, 2026, representing 15.0% of shares outstanding. This is an increase from the prior filing, which did not specify a stake percentage but listed Fidelity Management & Research Company LLC as a 5%+ owner. The filing is a routine passive stake update with no change in investment intent.

  • FMR LLC reported beneficial ownership of 25,286,624 shares of Tango Therapeutics common stock as of October 30, 2026.
  • The stake represents 15.0% of the outstanding shares.
  • Fidelity Management & Research Company LLC is the entity within FMR that owns 5% or greater of the shares.
  • The filing is an amendment to Schedule 13G, indicating passive investment intent under Rule 13d-1(b).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access